# The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment

> **NCT01667406** · PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 175 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Kisspeptin 1.6nmol/kg
- **DRUG:** Kisspeptin 3.2nmol/kg
- **DRUG:** Kisspeptin 6.4nmol/kg
- **DRUG:** Kisspeptin 9.6nmol/kg
- **DRUG:** Kisspeptin 12.8nmol/kg
- **DRUG:** Kisspeptin 9.6 nmol/kg double
- **DRUG:** Kisspeptin 9.6 nmol/kg + saline

## Key facts

- **NCT ID:** NCT01667406
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-01
- **Primary completion:** 2016-10-11
- **Final completion:** 2016-10-11
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667406, "The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01667406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*